Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve financial results for the quarter and nine months ended 31 December 2025, and the Interim Dividend for FY 2025-26